Cargando…
S205: INHIBITING THE ALARMIN-DRIVEN HEMATOPOIESIS-STROMAL CELLS CROSSTALK IN PRIMARY MYELOFIBROSIS AMELIORATES BONE MARROW FIBROSIS
Autores principales: | Gleitz, Hélène, Snoeren, Inge, Fuchs, Stijn, Nagai, James, Dugourd, Aurélien, Boys, Charlotte, Klöker, Vanessa, Pritchard, Jessica, Bindels, Eric, Te Boekhorst, Peter André Willem, Crysandt, Martina, Saez-Rodriguez, Julio, Vogl, Thomas, Kramann, Rafael, Costa, Ivan, Schneider, Rebekka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428437/ http://dx.doi.org/10.1097/01.HS9.0000967732.36177.f7 |
Ejemplares similares
-
Heterogeneous bone-marrow stromal progenitors drive myelofibrosis via a druggable alarmin axis
por: Leimkühler, Nils B., et al.
Publicado: (2021) -
Fibrosis driving myofibroblast precursors in MPN and new therapeutic pathways
por: Gleitz, Hélène F.E., et al.
Publicado: (2019) -
Understanding deregulated cellular and molecular dynamics in the haematopoietic stem cell niche to develop novel therapeutics for bone marrow fibrosis
por: Gleitz, Hélène FE, et al.
Publicado: (2018) -
Complement System and Alarmin HMGB1 Crosstalk: For Better or Worse
por: Gaboriaud, Christine, et al.
Publicado: (2022) -
Isolation of human bone marrow stromal cells from bone marrow biopsies for single-cell RNA sequencing
por: Gleitz, Hélène F.E., et al.
Publicado: (2021)